ArticleThe Journal of clinical investigation2022

Inhibiting the biogenesis of myeloid-derived suppressor cells enhances immunotherapy efficacy against mammary tumor progression.

Sean H Colligan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.